Core Viewpoint - The stock of Insilico Medicine (03696) rose nearly 5%, reaching a new high of 42.66 HKD per share, driven by the announcement of the DORA Community Edition, a free AI engine aimed at enhancing scientific research and content creation [1] Group 1: Product Launch and Features - Insilico Medicine launched the DORA Community Edition, a comprehensive AI engine designed for scientific research and content creation, which is free and can be self-deployed [1] - The DORA Community Edition aims to democratize access to cutting-edge research tools, promoting global scientific collaboration and increasing transparency in scientific research [1] - The upgraded DORA integrates seamlessly with various Foundry models, including the O3 Deep Research model, significantly enhancing the efficiency and quality of scientific content creation [1] Group 2: Additional Offerings - In addition to the Community Edition, Insilico Medicine offers a more comprehensive DORA SaaS version for users with advanced and specialized needs [1] - The DORA SaaS version provides access to pre-analyzed "protein-disease association" reports from Insilico's PandaOmics target discovery engine, offering deeper domain-specific insights [1] - The SaaS version connects to Insilico's data warehouse, supporting instant in-text citations [1]
英矽智能涨近5%创新高 宣布推出DORA社区版 获Microsoft Azure支持开源